Express Scripts Holding Co.

Registered Principal Details

Business Or Interest:
Pharmacy Benefits Management

Lobbying Interests:
All matters relating to pharmaceuticals, pharmacy benefits management and prescription drug programs.

CEO Name:
Keith Ebling
Vice President

Contact
JH
Jonah Houts
300 New Jersey Ave, NW #600
Washington, DC 20001
(202) 383-7983
jhouts@express-scripts.com
http://www.express-scripts.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Senate Bill 300
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

2013 Wisconsin Act 186

Other
Notification Date
9/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Matters pertaining to Maximum Allowable Cost (MAC) for pharmaceuticals.
Development, drafting or introduction of a proposal relating to
Matters pertaining to Maximum Allowable Cost (MAC) for pharmaceuticals.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Any Willing Provider (AWP) laws
Development, drafting or introduction of a proposal relating to
Matters pertaining to Any Willing Provider (AWP) laws

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Biosimilars
Development, drafting or introduction of a proposal relating to
Matters pertaining to Biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Healthcare Reform within and without PPACA
Development, drafting or introduction of a proposal relating to
Matters pertaining to Healthcare Reform within and without PPACA

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters relating to Pharmacy Services Administrative Organizations
Development, drafting or introduction of a proposal relating to
Matters relating to Pharmacy Services Administrative Organizations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to mail order pharmaceutical delivery
Development, drafting or introduction of a proposal relating to
Matters pertaining to mail order pharmaceutical delivery

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Any matters pertaining to pharmaceutical benefits management
Development, drafting or introduction of a proposal relating to
Any matters pertaining to pharmaceutical benefits management

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Controlled Substance Database Creation & Implementation by Pharmacy Examining Board
Development, drafting or introduction of a proposal relating to
Controlled Substance Database Creation & Implementation by Pharmacy Examining Board

Action Intended To Affect
Rule (by a state agency)

Notification Date
3/11/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
Total Lobbying Expenditures 2013
January - June
$28,300.37
2013
July - December
$27,000.00
2014
January - June
$27,000.00
2014
July - December
$27,000.00
Total $109,300.37
Total Hours Communicating 2013
January - June
24.50
2013
July - December
3.00
2014
January - June
2.75
2014
July - December
0.00
Total 30.25
Total Hours Other 2013
January - June
70.00
2013
July - December
101.50
2014
January - June
42.75
2014
July - December
54.25
Total 268.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
10%
2014
July - December
Total 2%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
5%
2013
July - December
2014
January - June
2014
July - December
Total 2%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
5%
2013
July - December
2014
January - June
2014
July - December
Total 2%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
5%
2013
July - December
2014
January - June
2014
July - December
Total 2%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
5%
2013
July - December
50%
2014
January - June
5%
2014
July - December
Total 20%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
5%
2013
July - December
2014
January - June
5%
2014
July - December
Total 2%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
25%
2013
July - December
2014
January - June
2014
July - December
Total 8%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
25%
2013
July - December
2014
January - June
5%
2014
July - December
Total 9%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
25%
2013
July - December
2014
January - June
5%
2014
July - December
Total 9%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
5%
2014
January - June
5%
2014
July - December
5%
Total 3%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
45%
2014
January - June
65%
2014
July - December
95%
Total 43%

Filed Statements of Lobbying Activity and Expenditures